A rare population of tumor antigen-specific CD4(+)CD8(+) double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells

BACKGROUND: High-affinity tumor antigen-specific T-cell receptor (TCR) gene is required to engineer potent T cells for therapeutic treatment of cancer patients. However, discovery of suitable therapeutic TCR genes is hampered by the fact that naturally occurring tumor antigen-specific TCRs are gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzaki, Junko, Tsuji, Takemasa, Chodon, Thinle, Ryan, Courtney, Koya, Richard C., Odunsi, Kunle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325755/
https://www.ncbi.nlm.nih.gov/pubmed/30626427
http://dx.doi.org/10.1186/s40425-018-0467-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325755/
https://www.ncbi.nlm.nih.gov/pubmed/30626427
http://dx.doi.org/10.1186/s40425-018-0467-y

Ejemplares similares